Johnson & Johnson China

Johnson & Johnson China is the regional division of the global healthcare leader, operating across pharmaceuticals and medical technology. The company has a significant footprint in China, including a major R&D center in Shanghai and manufacturing facilities in Suzhou and Xi'an. Its pharmaceutical portfolio, primarily under the Janssen brand, focuses on high-impact areas such as oncology, immunology, neuroscience, and infectious diseases. The MedTech division provides advanced surgical, orthopedic, and interventional solutions tailored to the Chinese market. J&J China is a key player in the local healthcare ecosystem, frequently collaborating with Chinese biotech firms like Legend Biotech to develop and commercialize innovative therapies. Following the spin-off of its consumer health business, the company has sharpened its focus on innovative medicine and medical technology in the region.